Current variables, definitions and endpoints of the European cardiovascular magnetic resonance registry

Anja Wagner, Oliver Bruder, Steffen Schneider, Detlev Nothnagel, Peter Buser, Guillem Pons-Lado, Thorsten Dill, Vinzenz Hombach, Massimo Lombardi, Albert C van Rossum, Juerg Schwitter, Jochen Senges, Georg V Sabin, Udo Sechtem, Heiko Mahrholdt, Eike Nagel, Anja Wagner, Oliver Bruder, Steffen Schneider, Detlev Nothnagel, Peter Buser, Guillem Pons-Lado, Thorsten Dill, Vinzenz Hombach, Massimo Lombardi, Albert C van Rossum, Juerg Schwitter, Jochen Senges, Georg V Sabin, Udo Sechtem, Heiko Mahrholdt, Eike Nagel

Abstract

Background: Cardiovascular magnetic resonance (CMR) is increasingly used in daily clinical practice. However, little is known about its clinical utility such as image quality, safety and impact on patient management. In addition, there is limited information about the potential of CMR to acquire prognostic information.

Methods: The European Cardiovascular Magnetic Resonance Registry (EuroCMR Registry) will consist of two parts: 1) Multicenter registry with consecutive enrolment of patients scanned in all participating European CMR centres using web based online case record forms. 2) Prospective clinical follow up of patients with suspected coronary artery disease (CAD) and hypertrophic cardiomyopathy (HCM) every 12 months after enrolment to assess prognostic data.

Conclusion: The EuroCMR Registry offers an opportunity to provide information about the clinical utility of routine CMR in a large number of cases and a diverse population. Furthermore it has the potential to gather information about the prognostic value of CMR in specific patient populations.

Figures

Figure 1
Figure 1
Baseline characteristics part one - Electronic case record forms to assess baseline characteristics of all enrolled patients and CMR procedural parameters.
Figure 2
Figure 2
Baseline characteristics part two - Electronic case record forms to report the results, complications and planed procedures after the CMR scan.
Figure 3
Figure 3
Specific protocol #1: Suspected-CAD - Electronic case record forms to document the cardiovascular risk profile for patients enrolled in the specific protocol "Suspected CAD".
Figure 4
Figure 4
Specific protocol #2: HCM-SCD - Electronic case record forms to determine the traditional risk factors for sudden cardiac death and CMR findings in patients with HCM enrolled in the specific protocol specific protocol "HCM-SCD".
Figure 5
Figure 5
Follow up - Electronic case record forms to study fatal endpoints, non-fatal endpoints as well as procedures after enrolment for all patients included in specific protocols ("Suspected-CAD" and "HCM-SCD").

References

    1. Wagner A, Mahrholdt H, Holly T, Elliott M, Regenfus M, Parker M, Klocke FJ, Bonow RO, Kim RJ, Judd RM. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet. 2003;361:374–9. doi: 10.1016/S0140-6736(03)12389-6.
    1. Rochitte CE, Tassi EM, Shiozaki AA. The emerging role of MRI in the diagnosis and management of cardiomyopathies. Curr Cardiol Rep. 2006;8:44–52. doi: 10.1007/s11886-006-0010-5.
    1. Mahrholdt H, Wagner A, Judd RM, Sechtem U, Kim RJ. Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J. 2005;26:1461–74. doi: 10.1093/eurheartj/ehi258.
    1. Douglas PS, Hendel RC, Cummings JE, Dent JM, Hodgson JM, Hoffmann U, Horn RJ, Hundley WG, Kahn CE Jr, Martin GR, Masoudi FA, Peterson ED, Rosenthal GL, Solomon H, Stillmann AE, Teague SD, Thomas JD, Tilkemeier PL, Guy Weigold W. ACCF/ACR/AHA/ASE/ASNC/HRS/NASCI/RSNA/SAIP/SCAI/SCCT/SCMR 2008 health policy statement on structured reporting in cardiovascular imaging. J Am Coll Cardiol. 2009;53:76–90. doi: 10.1016/j.jacc.2008.09.005.
    1. Klem I, Heitner JF, Shah DJ, Sketch MH Jr, Behar V, Weinsaft J, Cawley P, Parker M, Elliott M, Judd RM, Kim RJ. Improved detection of coronary artery disease by stress perfusion cardiovascular magnetic resonance with the use of delayed enhancement infarction imaging. J Am Coll Cardiol. 2006;47:1630–8. doi: 10.1016/j.jacc.2005.10.074.
    1. Douglas PS, Chen J, Gillam L, Hendel R, Hundley WG, Masoudi F, Patel MR, Peterson E. Achieving quality in cardiovascular imaging II: proceedings from the second American College of Cardiology - Duke University Medical Center Think Tank on Quality in Cardiovascular Imaging. JACC Cardiovasc Imaging. 2009;2:231–40. doi: 10.1016/j.jcmg.2008.11.012.
    1. Douglas P, Iskandrian AE, Krumholz HM, Gillam L, Hendel R, Jollis J, Peterson E, Chen J, Masoudi F, Mohler, McNamara RL, Patel MR, Spertus J. Achieving quality in cardiovascular imaging: proceedings from the American College of Cardiology-Duke University Medical Centre Think Tank on Quality in Cardiovascular Imaging. J Am Coll Cardiol. 2006;48:2141–51. doi: 10.1016/j.jacc.2006.06.076.
    1. American College of Radiology; Society of Cardiovascular Computed Tomography; Society for Cardiovascular Magnetic Resonance; American Society of Nuclear Cardiology; North American Society for Cardiac Imaging; Society for Cardiovascular Angiography and Interventions; Society of Interventional Radiology. ACCF/ACR/SCCT/SCMR/ASNC/NASCI/SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging. A report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group. J Am Coll Radiol. 2006. pp. 751–71.
    1. Pennell DJ, Sechtem UP, Higgins CB, Manning WJ, Pohost GM, Rademakers FE, van Rossum AC, Shaw LJ, Yucel EK. European Society of cardiology; Society for Cardiovascular Magnetic Resonance. Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report. J Cardiovasc Magn Reson. 2004;6:727–65. doi: 10.1081/JCMR-200038581.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner